BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26080113)

  • 21. Extracting biomarkers of commitment to cancer development: potential role of vibrational spectroscopy in systems biology.
    Theophilou G; Paraskevaidi M; Lima KM; Kyrgiou M; Martin-Hirsch PL; Martin FL
    Expert Rev Mol Diagn; 2015 May; 15(5):693-713. PubMed ID: 25804575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer.
    Gulmann C; Sheehan KM; Kay EW; Liotta LA; Petricoin EF
    J Pathol; 2006 Apr; 208(5):595-606. PubMed ID: 16518808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic applications for the early detection of cancer.
    Wulfkuhle JD; Liotta LA; Petricoin EF
    Nat Rev Cancer; 2003 Apr; 3(4):267-75. PubMed ID: 12671665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomics in cancer biomarkers discovery: challenges and applications.
    Sallam RM
    Dis Markers; 2015; 2015():321370. PubMed ID: 25999657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early detection of cancer--genetics or immunology?].
    Poletaev AB; Mukhamadeeva DR; Pukhalenko AI; Sviridov PV; Gantsev ShKh
    Vopr Onkol; 2015; 61(6):1021-8. PubMed ID: 26996000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies for plasma proteomic profiling of cancers.
    Omenn GS
    Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic Approaches for Biomarker Panels in Cancer.
    Tanase C; Albulescu R; Neagu M
    J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomics in alcohol research.
    Anni H; Israel Y
    Alcohol Res Health; 2002; 26(3):219-32. PubMed ID: 12875051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADAM Metalloprotease-Released Cancer Biomarkers.
    Herrlich P; Herrlich A
    Trends Cancer; 2017 Jul; 3(7):482-490. PubMed ID: 28718403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer genomics: technology, discovery, and translation.
    Tran B; Dancey JE; Kamel-Reid S; McPherson JD; Bedard PL; Brown AM; Zhang T; Shaw P; Onetto N; Stein L; Hudson TJ; Neel BG; Siu LL
    J Clin Oncol; 2012 Feb; 30(6):647-60. PubMed ID: 22271477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments.
    Yin JY; Dong Z; Liu ZQ; Zhang JT
    Biosci Rep; 2011 Feb; 31(1):1-15. PubMed ID: 20964625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perspective: cancer care and the new biology.
    Kaye SB
    J Pathol; 1999 Jan; 187(1):4-7. PubMed ID: 10341701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein Array-based Approaches for Biomarker Discovery in Cancer.
    Huang Y; Zhu H
    Genomics Proteomics Bioinformatics; 2017 Apr; 15(2):73-81. PubMed ID: 28392481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass spectrometry: uncovering the cancer proteome for diagnostics.
    van der Merwe DE; Oikonomopoulou K; Marshall J; Diamandis EP
    Adv Cancer Res; 2007; 96():23-50. PubMed ID: 17161675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomics in cancer research.
    Wu W; Hu W; Kavanagh JJ
    Int J Gynecol Cancer; 2002; 12(5):409-23. PubMed ID: 12366655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of 2D-DIGE in cancer proteomics toward personalized medicine.
    Kondo T; Hirohashi S
    Methods Mol Biol; 2009; 577():135-54. PubMed ID: 19718514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical proteomics in cancer: Where we are.
    Panis C; Pizzatti L; Souza GF; Abdelhay E
    Cancer Lett; 2016 Nov; 382(2):231-239. PubMed ID: 27561426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
    Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
    J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.